Cargando…

Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model

Currently, the most effective tuberculosis control method involves case finding and 6 months of chemotherapy. There is a need to improve our understanding about drug interactions, combination activities, and the ability to remove persistent bacteria using the current regimens, particularly in relati...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yanmin, Pertinez, Henry, Ortega-Muro, Fatima, Alameda-Martin, Laura, Liu, Yingjun, Schipani, Alessandro, Davies, Geraint, Coates, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958161/
https://www.ncbi.nlm.nih.gov/pubmed/27216065
http://dx.doi.org/10.1128/AAC.02548-15
_version_ 1782444277356298240
author Hu, Yanmin
Pertinez, Henry
Ortega-Muro, Fatima
Alameda-Martin, Laura
Liu, Yingjun
Schipani, Alessandro
Davies, Geraint
Coates, Anthony
author_facet Hu, Yanmin
Pertinez, Henry
Ortega-Muro, Fatima
Alameda-Martin, Laura
Liu, Yingjun
Schipani, Alessandro
Davies, Geraint
Coates, Anthony
author_sort Hu, Yanmin
collection PubMed
description Currently, the most effective tuberculosis control method involves case finding and 6 months of chemotherapy. There is a need to improve our understanding about drug interactions, combination activities, and the ability to remove persistent bacteria using the current regimens, particularly in relation to relapse. We aimed to investigate the therapeutic effects of three main components, rifampin (RMP), isoniazid (INH), and pyrazinamide (PZA), in current drug regimens using a modified version of the Cornell mouse model. We evaluated the posttreatment levels of persistent Mycobacterium tuberculosis in the organs of mice using culture filtrate derived from M. tuberculosis strain H37Rv. When RMP was combined with INH, PZA, or INH-PZA, significant additive activities were observed compared to each of the single-drug treatments. However, the combination of INH and PZA showed a less significant additive effect than either of the drugs used on their own. Apparent culture negativity of mouse organs was achieved at 14 weeks of treatment with RMP-INH, RMP-PZA, and RMP-INH-PZA, but not with INH-PZA, when conventional tests, namely, culture on solid agar and in liquid broth, indicated that the organs were negative for bacteria. The relapse rates for RMP-containing regimens were not significantly different from a 100% relapse rate at the numbers of mice examined in this study. In parallel, we examined the organs for the presence of culture filtrate-dependent persistent bacilli after 14 weeks of treatment. Culture filtrate treatment of the organs revealed persistent M. tuberculosis. Modeling of mycobacterial elimination rates and evaluation of culture filtrate-dependent organisms showed promise as surrogate methods for efficient factorial evaluation of drug combinations in tuberculosis in mouse models and should be further evaluated against relapse. The presence of culture filtrate-dependent persistent M. tuberculosis is the likely cause of disease relapse in this modified Cornell mouse model.
format Online
Article
Text
id pubmed-4958161
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-49581612016-07-26 Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model Hu, Yanmin Pertinez, Henry Ortega-Muro, Fatima Alameda-Martin, Laura Liu, Yingjun Schipani, Alessandro Davies, Geraint Coates, Anthony Antimicrob Agents Chemother Experimental Therapeutics Currently, the most effective tuberculosis control method involves case finding and 6 months of chemotherapy. There is a need to improve our understanding about drug interactions, combination activities, and the ability to remove persistent bacteria using the current regimens, particularly in relation to relapse. We aimed to investigate the therapeutic effects of three main components, rifampin (RMP), isoniazid (INH), and pyrazinamide (PZA), in current drug regimens using a modified version of the Cornell mouse model. We evaluated the posttreatment levels of persistent Mycobacterium tuberculosis in the organs of mice using culture filtrate derived from M. tuberculosis strain H37Rv. When RMP was combined with INH, PZA, or INH-PZA, significant additive activities were observed compared to each of the single-drug treatments. However, the combination of INH and PZA showed a less significant additive effect than either of the drugs used on their own. Apparent culture negativity of mouse organs was achieved at 14 weeks of treatment with RMP-INH, RMP-PZA, and RMP-INH-PZA, but not with INH-PZA, when conventional tests, namely, culture on solid agar and in liquid broth, indicated that the organs were negative for bacteria. The relapse rates for RMP-containing regimens were not significantly different from a 100% relapse rate at the numbers of mice examined in this study. In parallel, we examined the organs for the presence of culture filtrate-dependent persistent bacilli after 14 weeks of treatment. Culture filtrate treatment of the organs revealed persistent M. tuberculosis. Modeling of mycobacterial elimination rates and evaluation of culture filtrate-dependent organisms showed promise as surrogate methods for efficient factorial evaluation of drug combinations in tuberculosis in mouse models and should be further evaluated against relapse. The presence of culture filtrate-dependent persistent M. tuberculosis is the likely cause of disease relapse in this modified Cornell mouse model. American Society for Microbiology 2016-07-22 /pmc/articles/PMC4958161/ /pubmed/27216065 http://dx.doi.org/10.1128/AAC.02548-15 Text en Copyright © 2016 Hu et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Experimental Therapeutics
Hu, Yanmin
Pertinez, Henry
Ortega-Muro, Fatima
Alameda-Martin, Laura
Liu, Yingjun
Schipani, Alessandro
Davies, Geraint
Coates, Anthony
Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model
title Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model
title_full Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model
title_fullStr Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model
title_full_unstemmed Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model
title_short Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model
title_sort investigation of elimination rate, persistent subpopulation removal, and relapse rates of mycobacterium tuberculosis by using combinations of first-line drugs in a modified cornell mouse model
topic Experimental Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958161/
https://www.ncbi.nlm.nih.gov/pubmed/27216065
http://dx.doi.org/10.1128/AAC.02548-15
work_keys_str_mv AT huyanmin investigationofeliminationratepersistentsubpopulationremovalandrelapseratesofmycobacteriumtuberculosisbyusingcombinationsoffirstlinedrugsinamodifiedcornellmousemodel
AT pertinezhenry investigationofeliminationratepersistentsubpopulationremovalandrelapseratesofmycobacteriumtuberculosisbyusingcombinationsoffirstlinedrugsinamodifiedcornellmousemodel
AT ortegamurofatima investigationofeliminationratepersistentsubpopulationremovalandrelapseratesofmycobacteriumtuberculosisbyusingcombinationsoffirstlinedrugsinamodifiedcornellmousemodel
AT alamedamartinlaura investigationofeliminationratepersistentsubpopulationremovalandrelapseratesofmycobacteriumtuberculosisbyusingcombinationsoffirstlinedrugsinamodifiedcornellmousemodel
AT liuyingjun investigationofeliminationratepersistentsubpopulationremovalandrelapseratesofmycobacteriumtuberculosisbyusingcombinationsoffirstlinedrugsinamodifiedcornellmousemodel
AT schipanialessandro investigationofeliminationratepersistentsubpopulationremovalandrelapseratesofmycobacteriumtuberculosisbyusingcombinationsoffirstlinedrugsinamodifiedcornellmousemodel
AT daviesgeraint investigationofeliminationratepersistentsubpopulationremovalandrelapseratesofmycobacteriumtuberculosisbyusingcombinationsoffirstlinedrugsinamodifiedcornellmousemodel
AT coatesanthony investigationofeliminationratepersistentsubpopulationremovalandrelapseratesofmycobacteriumtuberculosisbyusingcombinationsoffirstlinedrugsinamodifiedcornellmousemodel